Lakhmir S. Chawla

This profile gathers the share dealings of Lakhmir S. Chawla across 2 companies, led by La Jolla Pharmaceutical Co and Revelation Biosciences, Inc. Over a trading history stretching from 28 September 2015 to 17 August 2026, the count stands at 59 filings.

On the market, this insider has only ever bought: 7 purchases, €80k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 52 share grants.

In size, the median ticket on the buying side is €5,848. Of 6 purchases, 6 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 18 August 2026 came the latest disclosure, a share grant in Revelation Biosciences, Inc. The last insider purchase was made public on 31 January 2019, 2,823 days ago. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.